MONDHE; Dilip Manikrao

Patent Applications and Registrations

Patent applications and USPTO patent grants for MONDHE; Dilip Manikrao.The latest application filed is for "solid dispersion comprising an anticancer compound for improved solubility and efficacy".

Company Profile

2.5.10

MONDHE; Dilip Manikrao - Jammu IN
Mondhe; Dilip Manikrao - Jammu Tawi IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Solid Dispersion Comprising An Anticancer Compound For Improved Solubility And Efficacy App 20210308116 - BHARATE; Sonali Sandip ; et al.	2021-10-07
Fused pyrimidines as isoform selective phosphoinositide-3-kinase-alpha inhibitors and process for preparation thereof Grant 10,696,688 - Bharate , et al. June 30, 2	2020-06-30
Fused Pyrimidines As Isoform Selective Phosphoinositide-3-kinase-alpha Inhibitors And Process For Preparation Thereof App 20200031845 - BHARATE; Sandip Bibishan ; et al.	2020-01-30
1,3,5 -triazine based PI3K inhibitors as anticancer agents and a process for the preparation thereof Grant 9,951,040 - Thatikonda , et al. April 24, 2	2018-04-24
Novel 1,3,5 -triazine Based Pi3k Inhibitors As Anticancer Agents And A Process For The Preparation Thereof App 20170342049 - Thatikonda; Thanusha ; et al.	2017-11-30
2-anilino nicotinyl linked 2-amino benzothiazole conjugates and process for the preparation thereof Grant 9,029,553 - Kamal , et al. May 12, 2	2015-05-12
2-anilino Nicotinyl Linked 2-amino Benzothiazole Conjugates And Process For The Preparation Thereof App 20130324734 - Kamal; Ahmed ; et al.	2013-12-05
Use Of Semi Synthetic Analogues Of Boswellic Acids For Anticancer Activity App 20090298938 - Qazi; Ghulam Nabi ; et al.	2009-12-03
Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs App 20080138452 - Johri; Rakesh Kamal ; et al.	2008-06-12
Pharmaceutical composition useful for the treatment of hepatocellular carcinoma App 20060280817 - Saxena; Ajit Kumar ; et al.	2006-12-14
Hepatocurative effect of Emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs App 20060121138 - Johri; Rakesh Kamal ; et al.	2006-06-08
Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs Grant 7,001,619 - Johri , et al. February 21, 2	2006-02-21
Hepatocurative effect of emblica officinalis against CYP 450 bio-activation hepatotoxicity of drugs App 20030185922 - Johri, Rakesh Kamal ; et al.	2003-10-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.